Novavax Stock In The News

NVAX Stock  USD 7.56  0.13  1.69%   
Our overall analysis of Novavax's news coverage and content from conventional and social sources shows investors' bearish mood towards Novavax. The specific impact of Novavax news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Novavax's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Novavax headlines in addition to utilizing other, more conventional financial analysis modules. Check out Novavax Backtesting and Novavax Hype Analysis.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Novavax Today Top News and Investor Outlook

Yahoo News
2 Beaten-Down Stocks Near Their 52-Week Lows That Aren't Worth Buying
https://finance.yahoo.com/news/2-beaten-down-stocks-near-111500652.html
 Bullish
Yahoo News
Need To Know: Analysts Just Made A Substantial Cut To Their Novavax, Inc. (NASDAQ:NVAX) Estimates
https://finance.yahoo.com/news/know-analysts-just-made-substantial-183147939.html
 Bullish
Yahoo News
Novavax Announces Changes to Board of Directors
https://finance.yahoo.com/news/novavax-announces-changes-board-directors-120000103.html
 Bullish
Yahoo News
Novavax, Inc. (NASDAQ:NVAX) Shares Could Be 45% Below Their Intrinsic Value Estimate
https://finance.yahoo.com/news/novavax-inc-nasdaq-nvax-shares-122412365.html
 Bullish
Yahoo News
Novavax Inc (NVAX) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Financial ...
https://finance.yahoo.com/news/novavax-inc-nvax-q4-2024-071122123.html
 Neutral
Yahoo News
Novavax to Participate in Upcoming March Investor Conferences
https://finance.yahoo.com/news/novavax-participate-upcoming-march-investor-210500594.html
 Bullish
Yahoo News
Novavax Reports Smaller Q4 Loss, Shifts Focus From Commercializing COVID-19 Vaccine To Maximize Value
https://finance.yahoo.com/news/novavax-reports-smaller-q4-loss-162410124.html
 Neutral
Yahoo News
Novavax shares up on fourth quarter earnings beat
https://finance.yahoo.com/news/novavax-shares-fourth-quarter-earnings-142515939.html
 Bullish
Yahoo News
Novavax Reports Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights
https://finance.yahoo.com/news/novavax-reports-fourth-quarter-full-130000262.html
 Neutral
Yahoo News
Why Moderna Inc. (MRNA) Surged On Friday?
https://finance.yahoo.com/news/why-moderna-inc-mrna-surged-053729549.html
 Neutral

Novavax Past News Timeline

From Mar 26 to Dec 25Use up and down arrows to move selectionTo Mar 26Use up and down arrows to move upper selectionFrom Dec 25Use up and down arrows to move lower selectionUse TAB select grip buttons or up and down arrows to change selection100%
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Novavax and other traded companies coverage with news coverage. We help investors stay connected with Novavax headlines for the 25th of March to make an informed investment decision based on correlating the impacts of news items on Novavax Stock performance. Please note that trading solely based on the Novavax hype is not for everyone as timely availability and quick action are needed to avoid losses.
Novavax's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Novavax investors visualize upcoming and past events in order to time the market based on Novavax noise-free hype analysis.
Novavax stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Novavax earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Novavax that are available to investors today. That information is available publicly through Novavax media outlets and privately through word of mouth or via Novavax internal channels. However, regardless of the origin, that massive amount of Novavax data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Novavax news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Novavax relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Novavax's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Novavax alpha.

Novavax Largest EPS Surprises

Earnings surprises can significantly impact Novavax's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-08-10
2020-06-30-0.42-0.30.1228 
2019-11-07
2019-09-30-0.98-1.11-0.1313 
2012-11-02
2012-09-30-0.87-1.0-0.1314 
2012-03-09
2011-12-31-0.77-0.60.1722 
2020-05-11
2020-03-31-0.78-0.580.225 
2009-11-06
2009-09-30-1.8-1.60.211 
View All Earnings Estimates

Novavax Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Novavax Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
zacks News
19th of March 2025
Novavax Stock Dips While Market Gains Key Facts
at zacks.com 
Yahoo News
17th of March 2025
Investors Heavily Search Novavax, Inc. Here is What You Need to Know
at finance.yahoo.com 
Simply Wall St News at Macroaxis
12th of March 2025
Acquisition by Shiver John W. of 23840 shares of Novavax subject to Rule 16b-3
at simplywall.st 
news
11th of March 2025
5 years ago, the WHO declared COVID a pandemic. Heres a look at the disease by the numbers
at abcnews.go.com 
Macroaxis News
6th of March 2025
Disposition of 1107 shares by Young James F of Novavax at 14.28 subject to Rule 16b-3
at MacroaxisInsider 
Yahoo News
4th of March 2025
Disposition of 5375 shares by Ohara Elaine of Novavax at 8.33 subject to Rule 16b-3
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
28th of February 2025
Decoding Novavax Inc A Strategic SWOT Insight
at gurufocus.com 
seekingalpha News
26th of February 2025
Novavax Q4 2024 Earnings Preview
at seekingalpha.com 
zacks News
10th of February 2025
Novavax Outperforms Broader Market What You Need to Know
at zacks.com 
Macroaxis News
23rd of January 2025
Disposition of 83196 shares by Jacobs John C of Novavax subject to Rule 16b-3
at MacroaxisInsider 

Novavax Investors Sentiment

The influence of Novavax's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Novavax. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Novavax's public news can be used to forecast risks associated with an investment in Novavax. The trend in average sentiment can be used to explain how an investor holding Novavax can time the market purely based on public headlines and social activities around Novavax. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Novavax's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Novavax's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Novavax's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Novavax.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Novavax in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Novavax's short interest history, or implied volatility extrapolated from Novavax options trading.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.